相关实验视频
Updated: Sep 11, 2025

06:27
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
562
引发瘤的遗传学和治疗驱动IDH突变质瘤的分离分子进化
bioRxiv : the preprint server for biology
|August 12, 2025
概括
在治疗期间,遗传变化驱动IDH突变质瘤的演变. 星系细胞瘤和小类质瘤会发生明显的变化,导致治疗耐药性和这些脑瘤的更糟糕的结果.
科学领域:
- 神经瘤学神经瘤学
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- IDH突变性星系细胞瘤和寡类质瘤是缓慢生长的质瘤,存活率可变.
- 瘤再生和治疗耐药性是管理这些脑瘤的常见挑战.
- 了解治疗压力下的遗传进化对于改善患者的治疗结果至关重要.
研究的目的:
- 为了识别与IDH突变质瘤的瘤进化相关的遗传变化,以应对治疗.
- 为了在治疗期间比较星系细胞瘤和寡质细胞瘤之间的基因组分歧.
主要方法:
- 来自Glioma纵向分析 (GLASS) 联盟的206个IDH突变质瘤患者样本的多时间点全基因组和全外基因组测序.
- 已知基因组标记物的验证和发现新的遗传变异.
- 突变特征分析,以评估temozolomide和放射治疗的影响.
主要成果:
- 在复发性寡质瘤中观察到PIK3CA,PIK3R1和NOTCH1的获得点突变.
- 焦点瘤基因放大和CDKN2A同卵性缺失与天体细胞瘤中的染色体失衡有关.
- 独特的突变特征 (SBS11,SBS119,ID8) 与特定的治疗方法和质瘤亚型有关.
结论:
- 在治疗选择性压力下,寡头质瘤和星系细胞瘤表现出不同的基因组适应策略.
- 获得的驱动器变化和全基因组变化的趋同,标志着对治疗耐药克隆的选择.
- 研究结果表明,在IDH突变质瘤中,在化疗和放射治疗后,DNA损伤反应机制不同.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

